Targeted Nanoparticle for Co‐delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain Metastasis is a research paper published in Small (2022). On theSindex it has a DataRank of 0. It has been cited 48 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Biomedical Imaging and Bioengineering
Grant: R01EB003268
NCI NIH HHS
Grant: R44 CA217534
Canadian Institutes for Health Research
Grant: FRN 119312
NCI NIH HHS
Grant: R44 CA265752
NCI NIH HHS
Grant: R44 CA265751
National Institutes of Health
Grant: 1R44CA217534-01
Nanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer
National Institutes of Health
Grant: 1R44CA265752-01A1
In Situ Tumor Vaccination with a Nano-oligo Therapeutic to Induce Whole-body Antitumor Immune Response
National Institutes of Health
Grant: 9R01EB003268-06
Ultrasound Therapy Delivery Through Intact Skull
National Institutes of Health
Grant: 4R44CA265751-02
Novel Nano-immunotherapy for Treatment of Non-small Cell Lung Cancer
Oregon Health and Science University
National Institutes of Health
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals